Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia (VITAL)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Status: Enrolling

Conditions: Cervical Intraepithelial Neoplasia

Study type: Observational

Funder types: Other

Identifiers

NCT06611020

570/20

Details and patient eligibility

About

HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions

Full description

Patients treated for HPV-related disease are counseled about the potential protective role of HPV vaccination. The investigators will monitor the risk of HPV recurrence in pateints who choce to have vaccination and who did not.

Enrollment: 600 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Treatment of HPV-related disease

Exclusion criteria

• Previous HPV vaccination

Trial design

600 participants in 1 patient group

treatment of HPV-related disease with or without vaccination